Managers / Q2 2020 · view latest →
KINGS POINT CAPITAL MANAGEMENT
CIK 0001388736 · 60 CUTTERMILL ROAD, SUITE 516, GREAT NECK, NY, 11021 · 516-439-5105
Summary
Kings Point Capital Management reported $690M in U.S.-listed holdings across 439 positions for Q2 2020.
Its largest position, AAPL, represents 5.2% of the portfolio.
Compared with Q1 2020, the fund opened 33 new positions and exited 44.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 46.9% · $324M
- Other · 42.4% · $292M
- ETP · 7.2% · $50M
- ADR · 1.4% · $10M
- NY Reg Shrs · 1.1% · $7M
- Other · 1.1% · $7M
Quarter-over-Quarter Changes full breakdown →
vs Q1 2020 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| AON PLC SHS | NEW | +59.6K | 59.6K | +$11M | $11M |
| RAYTHEON TECHNOLOGIES CORP | NEW | +120.2K | 120.2K | +$7M | $7M |
| FQIDIGITAL RLTY TR INC | NEW | +14.1K | 14.1K | +$2M | $2M |
| ALPS ETF TR ALERIAN | NEW | +17.5K | 17.5K | +$431,000 | $431,000 |
| DRIVE SHACK INC | NEW | +105.0K | 105.0K | +$194,000 | $194,000 |
| FSKFS KKR CAPITAL CORP | NEW | +4.8K | 4.8K | +$67,000 | $67,000 |
| ROYALTY PHARMA PLC SHS | NEW | +1.0K | 1.0K | +$49,000 | $49,000 |
| VANECK VECTORS ETF TR | NEW | +1.2K | 1.2K | +$44,000 | $44,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2020
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2022 | $1.1B | 576 | May 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $1.2B | 635 | Feb 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $1.1B | 569 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $1.1B | 539 | Aug 13, 2021 | RESTATEMENT | changes · EDGAR ↗ |
| Q1 2021 | $1.0B | 536 | May 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $938M | 492 | Feb 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $801M | 475 | Nov 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $690M | 439 | Aug 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $568M | 450 | May 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $678M | 488 | Feb 14, 2020 | RESTATEMENT | changes · EDGAR ↗ |
| Q3 2019 | $591M | 477 | Nov 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $548M | 427 | Aug 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $503M | 355 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $448M | 350 | Feb 13, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.